US 10064889
Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
granted A61KA61K31/573A61K31/728
Quick answer
US patent 10064889 (Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof) held by BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
- Grant date
- Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/573, A61K31/728, A61K31/737, A61K31/738